Cargando…

Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson’s Disease

BACKGROUND: Environmental substances such as pesticides are well-known in link with Parkinson’s disease (PD) risk. Enzymes including cytochromes P450 (CYPs), esterases and glutathione S-transferases (GSTs) are responsible for the xenobiotic metabolism and may functionally compensate each other for s...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Hui-Hui, Li, Bao-Qing, Wu, Ke-Yun, Yan, Hai-Dan, Gu, Meng-Jie, Yao, Xing-Hao, Dong, Hao-Jia, Zhang, Xiong, Zhu, Jian-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099289/
https://www.ncbi.nlm.nih.gov/pubmed/35572141
http://dx.doi.org/10.3389/fnagi.2022.888942
_version_ 1784706570641211392
author Fan, Hui-Hui
Li, Bao-Qing
Wu, Ke-Yun
Yan, Hai-Dan
Gu, Meng-Jie
Yao, Xing-Hao
Dong, Hao-Jia
Zhang, Xiong
Zhu, Jian-Hong
author_facet Fan, Hui-Hui
Li, Bao-Qing
Wu, Ke-Yun
Yan, Hai-Dan
Gu, Meng-Jie
Yao, Xing-Hao
Dong, Hao-Jia
Zhang, Xiong
Zhu, Jian-Hong
author_sort Fan, Hui-Hui
collection PubMed
description BACKGROUND: Environmental substances such as pesticides are well-known in link with Parkinson’s disease (PD) risk. Enzymes including cytochromes P450 (CYPs), esterases and glutathione S-transferases (GSTs) are responsible for the xenobiotic metabolism and may functionally compensate each other for subtypes in the same class. We hypothesize that the genetic effects of each class modulate PD risk stronger in a synergistic way than individually. METHODS: We selected 14 polymorphic loci out of 13 genes which encode enzymes in the classes of CYP, esterase, and GST, and recruited a cohort of 1,026 PD and control subjects from eastern China. The genotypes were identified using improved multiplex ligation detection reaction and analyzed using multiple models. RESULTS: A total of 13 polymorphisms remained after Hardy-Weinberg equilibrium analysis. None of the polymorphisms were independently associated with PD risk after Bonferroni correction either by logistic regression or genetic models. In contrast, interaction analyses detected increased resistance to PD risk in individuals carrying the rs12441817/CC (CYP1A1) and rs2070676/GG + GC (CYP2E1) genotypes (P = 0.002, OR = 0.393, 95% CI = 0.216–0.715), or carrying the GSTM1-present, GSTT1-null, rs156697/AG + GG (GSTO2) and rs1695/AA (GSTP1) genotypes (P = 0.003, OR = 0.348, 95% CI = 0.171–0.706). The synergistic effect of GSTs on PD was primarily present in females (P = 0.003). No synergistic effect was observed within genotypes of esterases. CONCLUSION: We demonstrate a presence of synergistic but not individual impact on PD susceptibility in polymorphisms of CYPs and GSTs. The results indicate that the genetic interplay leads the way to PD development for xenobiotic metabolizing enzymes.
format Online
Article
Text
id pubmed-9099289
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90992892022-05-14 Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson’s Disease Fan, Hui-Hui Li, Bao-Qing Wu, Ke-Yun Yan, Hai-Dan Gu, Meng-Jie Yao, Xing-Hao Dong, Hao-Jia Zhang, Xiong Zhu, Jian-Hong Front Aging Neurosci Neuroscience BACKGROUND: Environmental substances such as pesticides are well-known in link with Parkinson’s disease (PD) risk. Enzymes including cytochromes P450 (CYPs), esterases and glutathione S-transferases (GSTs) are responsible for the xenobiotic metabolism and may functionally compensate each other for subtypes in the same class. We hypothesize that the genetic effects of each class modulate PD risk stronger in a synergistic way than individually. METHODS: We selected 14 polymorphic loci out of 13 genes which encode enzymes in the classes of CYP, esterase, and GST, and recruited a cohort of 1,026 PD and control subjects from eastern China. The genotypes were identified using improved multiplex ligation detection reaction and analyzed using multiple models. RESULTS: A total of 13 polymorphisms remained after Hardy-Weinberg equilibrium analysis. None of the polymorphisms were independently associated with PD risk after Bonferroni correction either by logistic regression or genetic models. In contrast, interaction analyses detected increased resistance to PD risk in individuals carrying the rs12441817/CC (CYP1A1) and rs2070676/GG + GC (CYP2E1) genotypes (P = 0.002, OR = 0.393, 95% CI = 0.216–0.715), or carrying the GSTM1-present, GSTT1-null, rs156697/AG + GG (GSTO2) and rs1695/AA (GSTP1) genotypes (P = 0.003, OR = 0.348, 95% CI = 0.171–0.706). The synergistic effect of GSTs on PD was primarily present in females (P = 0.003). No synergistic effect was observed within genotypes of esterases. CONCLUSION: We demonstrate a presence of synergistic but not individual impact on PD susceptibility in polymorphisms of CYPs and GSTs. The results indicate that the genetic interplay leads the way to PD development for xenobiotic metabolizing enzymes. Frontiers Media S.A. 2022-04-29 /pmc/articles/PMC9099289/ /pubmed/35572141 http://dx.doi.org/10.3389/fnagi.2022.888942 Text en Copyright © 2022 Fan, Li, Wu, Yan, Gu, Yao, Dong, Zhang and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Fan, Hui-Hui
Li, Bao-Qing
Wu, Ke-Yun
Yan, Hai-Dan
Gu, Meng-Jie
Yao, Xing-Hao
Dong, Hao-Jia
Zhang, Xiong
Zhu, Jian-Hong
Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson’s Disease
title Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson’s Disease
title_full Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson’s Disease
title_fullStr Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson’s Disease
title_full_unstemmed Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson’s Disease
title_short Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson’s Disease
title_sort polymorphisms of cytochromes p450 and glutathione s-transferases synergistically modulate risk for parkinson’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099289/
https://www.ncbi.nlm.nih.gov/pubmed/35572141
http://dx.doi.org/10.3389/fnagi.2022.888942
work_keys_str_mv AT fanhuihui polymorphismsofcytochromesp450andglutathionestransferasessynergisticallymodulateriskforparkinsonsdisease
AT libaoqing polymorphismsofcytochromesp450andglutathionestransferasessynergisticallymodulateriskforparkinsonsdisease
AT wukeyun polymorphismsofcytochromesp450andglutathionestransferasessynergisticallymodulateriskforparkinsonsdisease
AT yanhaidan polymorphismsofcytochromesp450andglutathionestransferasessynergisticallymodulateriskforparkinsonsdisease
AT gumengjie polymorphismsofcytochromesp450andglutathionestransferasessynergisticallymodulateriskforparkinsonsdisease
AT yaoxinghao polymorphismsofcytochromesp450andglutathionestransferasessynergisticallymodulateriskforparkinsonsdisease
AT donghaojia polymorphismsofcytochromesp450andglutathionestransferasessynergisticallymodulateriskforparkinsonsdisease
AT zhangxiong polymorphismsofcytochromesp450andglutathionestransferasessynergisticallymodulateriskforparkinsonsdisease
AT zhujianhong polymorphismsofcytochromesp450andglutathionestransferasessynergisticallymodulateriskforparkinsonsdisease